品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Discovery Antibodies/NPS 2390/25 mg/N-340-25 mg

价格
¥3060.00
货号:N-340-25mg
浏览量:87
品牌:Discovery
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat #: N-340
  • Lyophilized Powder
  • Bioassay Tested
  • Source Synthetic
    MW: 307.4
    Purity: >98%
    Effective concentration 10 nM – 1 uM.
      • NPS 2390
    Chemical name N-(1-adamantyl)quinoxaline-2-carboxamide.
    Molecular formula C19H21N3O.
    CAS No.: 226878-01-9.
    PubChem CID 7067728
    Activity NPS 2390, a quinoxaline derivative, is a potent and selective non-competitive antagonist of Group I mGluRs, acting on mGluR1 and mGluR5 with IC50 values of to 5.2 and 82 nM, respectively, while having no effect on mGluR2, mGluR8 and other targets at 30 μM1-3.
      • Mabire, D. et al. (2005) J. Med. Chem48, 2134.
      • Lavreysen, H. et al. (2003) Mol. Pharmacol63, 1082.
      • Van Wagenen, B.C. et al. (2000) Abstr. Soc. Neurosci. Presentation No. 618, 3.
    Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
    Solubility Up to 25 mM in DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
    Storage of solutions -20°C.
      • NPS 2390
        Alomone Labs NPS 2390 inhibits mGluR1-mediated Ca2+ mobilization in U2OS cells.
        Dose response of normalized inhibition of human mGluR1 mediated, L-Glutamate evoked Ca2+ mobilization by NPS 2390 (#N-340). IC50 was determined at 56.7 nM. hmGluR1-expressing cells were loaded with calcium-sensitive dye, incubated with a range of concentrations of NPS 2390, and stimulated by 15 µM L-Glutamate (EC80). Changes in intracellular Ca2+ following stimulation were detected as changes in maximum relative fluorescence (RLU) using FLIPRTETRA™.
    References - Scientific background
    • 1. Mabire, D. et al. (2005) J. Med. Chem48, 2134.
    • 2. Lavreysen, H. et al. (2003) Mol. Pharmacol63, 1082.
    • 3. Van Wagenen, B.C. et al. (2000) Abstr. Soc. Neurosci. Presentation No. 618, 3.
    • 4. O"Brien, J.A. et al. (2003) Mol. Pharmacol. 64, 731.
    • 5. Satow, A. et al. (2008) J. Pharmacol. Exp. Ther. 326, 577.
    • 6. Eom, H.S. et al. (2016) PLoS One 11, e0147538.
    • 7. Lu, Y.M. et al. (1996) J. Neurosci. 17, 5196.
      • NPS 2390, a quinoxaline derivative, is a synthetic, potent, selective and non-competitive antagonist of group I metabotropic glutamate receptors comprising mGluR1 and mGluR5 receptors with IC50 values of 5.2 and 8.2 nM respectively7. The compound shows very low affinity towards other mGluR receptors.

        Several studies suggest that NPS 2390 acts on a site that is different from the glutamate binding pocket. It is likely that the compound acts at the transmembrane segment VII region of the receptors1-3.

        Metabotropic glutamate receptors (mGluRs) are G protein coupled receptors (GPCR) that play an important role in synaptic plasticity and other neuro-physiological and pathological processes including a major role in central sensitization and neuropathic pain. Type 1 mGluRs are mainly found in somatodendritic domains and postsynaptically regulate neuronal excitability and synaptic transmission through several intracellular second messenger systems4,5. The mGlu1 receptors play an important role in motor learning and motor coordination whereas mGlu5 receptors contribute to induction of long-term potentiation and associative learning6.

    Target mGluR1, mGluR5 receptors
    receive a 5 mg free trial sample!
    Last update: 25/09/2019

    NPS 2390 (#N-340) is a highly pure, synthetic, and biologically active compound.

    For research purposes only, not for human use
    Discovery Antibodies的Cyclin dependant kinase 2 (CDK2) is a serine/threonine protein kinase which controls both G1/S and G2/M transitions. CDKs along with cyclins and CDK inhibitors regulate cell cycle progression. Specific cyclins activate different CDKs; in early G1, CDK2 pairs with cyclin E to promote entry into the S phase before switching to partner with cyclin A to drive the cell through S phase. Once activated CDKs phosphorylate downstream proteins to initiate signalling cascades. CDK2 phosphorylates and inactivates the RB1 (pRb) tumour suppressor family of proteins.CDK的活动受到严格控制。CDK2活性可以被包括P21在内的一系列抑制剂抑制。细胞周期失调和增殖控制的丧失与细胞转化和癌症密切相关。CDK2在DNA损伤反应(DDR)中的细胞周期停滞中也似乎起着积极作用,它的抑制作用会阻碍DDR,并使细胞对电离辐射敏感,从而诱导细胞死亡。该抗体与AlexaFluor®488偶联。AlexaFluor®488是一种流行的鲜绿色荧光染料,具有高pH稳定性。
    • 资质认证

      获得国家资质,权威认证!

    • 全国联保

      全国联保,官方无忧售后

    • 正规发票

      正规发票,放心购买

    • 签订合同

      签订合同,保障您的权益

    /**/